CD8A and influenza: At present, the traditional drug oseltamivir that significantly decreased influenza-specific CD8+ effector T cells and tissue-resident and circulating effector memory and central memory CD8+ T cells [27], traditional vaccinations such as trivalent inactivated and attenuated vaccines are inadequate to provide immediate protection against sudden influenza outbreaks [40, 41].